Sakima Smith is a Cardiology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 157 publications with 1,748 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
473 W 12th Ave
Suite 200
Columbus, OH 432101252
Telephone
614-293-8962Registry record last updated 2 Jul 2014.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20231 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.3%Beta blocker21.4%Metoprolol Succinate74%Carvedilol27%Part D≥29 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)15%Entresto100%Part D≥16 patients+ 7 more classes in this area
Metabolism & gastrointestinal
11.8%SGLT2 inhibitor4.7%Farxiga100%Part D<11 patientsPotassium supplement4.6%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Blood & clotting
8%Factor Xa inhibitor4.9%Eliquis100%Part D<11 patientsVitamin K antagonist3%Warfarin Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2017–2025 per NIH RePORTER. The latest:
- Defining Novel Cardiovascular Mechanisms For TKI Induced Excitability
Ohio State University
FY2025$400,814R01HL160590 - Defining Novel Cardiovascular Mechanisms For TKI Induced Excitability
Ohio State University
FY2024$392,797R01HL160590
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms
Journal of Molecular and Cellular Cardiology
2024 - Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
Heart Failure Clinics
2022 - Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5
Clinical and Translational Science
2022 - The Modifying Role of Resilience on Allostatic Load and Cardiovascular Disease Risk in the Jackson Heart Study
Journal of Racial and Ethnic Health Disparities
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”